Medical specialists from France tagged as investigators in clinical trials studying Churg-Strauss Syndrome
Total 11 results
-
Antoine NeelSeen in:
- Nantes Cedex 1, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Arnaud BourdinSeen in:
- Montpellier Cedex 5, GSK Investigational Site
- Montpellier cedex 5, GSK Investigational Site
Trials:- NCT04718389 (Principal Investigator)
- NCT05263934 (Principal Investigator)
Conditions: -
Benjamin TerrierSeen in:
- Paris, GSK Investigational Site
- Paris, Hôpitaux Cochin - Port Royal
Trials:- NCT05263934 (Principal Investigator)
- NCT04885452 (Principal Investigator)
-
Bruno VillemagneSeen in:
- La Roche Sur Yon, La Roche-sur-Yon, CHD Vendée
- La Roche sur Yon Cedex 9, GSK Investigational Site
- La Roche sur Yon, CHD Vendée
- Vendee, La Roche-sur-Yon, CHD Vendée
Trials:- NCT05263934 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05023980 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Carole LacoutSeen in:
- Angers Cedex 09, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Claire de MoreuilSeen in:
- Brest Cedex, GSK Investigational Site
- Brest, CHU La Cavale Blanche
Trials:- NCT05263934 (Principal Investigator)
- NCT01034969 (Principal Investigator)
-
Guillaume LefevreSeen in:
- Lille Cedex, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Jean-Emmanuel KahnSeen in:
- Suresnes, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Jean-François ViallardSeen in:
- Pessac, CHU Bordeaux - Hopital Haut-Leveque
- Pessac, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
- NCT05879757 (Principal Investigator)
-
Loic GuillevinSeen in:
- Paris, Cochin Hospital, Université Paris-descartes
Trials:- NCT01066208 (Principal Investigator)
-
stanislas faguerSeen in:
- Toulouse Cedex 9, CHU de Toulouse - Hôpital Rangueil
- Toulouse, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
- NCT02664753 (Principal Investigator)
Clinical Trials on Churg-Strauss Syndrome
-
Brigham and Women's HospitalGlaxoSmithKlineCompletedChurg Strauss SyndromeUnited States
-
University Hospital Schleswig-HolsteinGlaxoSmithKlineCompletedChurg Strauss SyndromeGermany
-
University of PennsylvaniaUniversity of South Florida; University of OxfordCompletedVasculitis | Churg-Strauss Syndrome (CSS) | Microscopic Polyangiitis (MPA) | Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA) | Granulomatosis With Polyangiitis (Wegener's) (GPA) | Wegener Granulomatosis (WG) | ANCA-Associated Vasculitis (AAV)United States
-
Hospices Civils de LyonUnknownChurg-Strauss SyndromeSwitzerland
-
GlaxoSmithKlineActive, not recruiting
-
Mounzer AghaTerminated
-
Fernando FervenzaGenentech, Inc.; Biogen; National Center for Research Resources (NCRR)Terminated
-
University of OxfordAmerican College of Rheumatology; The European League Against Rheumatism (EULAR) and other collaboratorsUnknownGiant Cell Arteritis | Wegener's Granulomatosis | Microscopic Polyangiitis | Polyarteritis Nodosa | Takayasu Arteritis | Churg Strauss SyndromeKorea, Republic of, United States, Germany, Australia, Japan, Ireland, Belgium, Italy, Denmark, Slovenia, Switzerland, Canada, Argentina, Austria, China, Czech Republic, Egypt, Finland, France, Hungary, India, Mexico, Netherlands, New... and more
-
Children's Hospital Medical Center, CincinnatiCompletedEosinophilic Gastroenteritis | Eosinophilic Esophagitis | Churg-Strauss Syndrome | Hypereosinophilic SyndromesUnited States
-
AstraZenecaActive, not recruitingEosinophilic Granulomatous VasculitisUnited States, Canada, France, Italy, Israel, United Kingdom, Japan, Germany, Belgium